Meeting
2023 ASCO Annual Meeting
The impact of surgery on patients with VHL-associated tumors: An international patient survey.
Authors
Murali Sundaram
Merck & Co., Inc., Rahway, NJ
Murali Sundaram , Christian Atkinson , Joshua Mann , Charley Cooper , Gavin Taylor-Stokes , Othon Iliopoulos
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4517)
DOI
10.1200/JCO.2023.41.16_suppl.4517
Abstract #
4517
Poster Bd #
9
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Burden of surgeries and surgical complications in patients with Von Hippel Lindau (VHL) disease before and after treatment with belzutifan.
First Author: Lin Wang
Poster
2022 ASCO Genitourinary Cancers Symposium
Healthcare resource utilization (HRU) and costs among patients with Von Hippel-Lindau disease (VHL)-associated renal cell carcinoma (RCC): A retrospective administrative claims analysis.
First Author: Eric Jonasch
Poster
2023 ASCO Annual Meeting
Germline mutations in hereditary renal cell carcinoma (RCC) genes among 32,240 patients with all cancer types.
First Author: Maria Isabel Carlo
Poster
2023 ASCO Annual Meeting
Real-world outcomes and safety in patients with VHL associated tumors receiving belzutifan.
First Author: Anusha Chidharla